A new guideline for treating obesity in children and adolescents says medication can be helpful, but that health providers ...

Type 5 diabetes, a newly recognised form of the disease, affects lean and malnourished teens and young adults in low- and middle-income countries. Officially classified by the International Diabetes ...

Given the success of the previous collection, Digital Technology in the Management and Prevention of Diabetes: Volume II, we are pleased to announce the ...

Nearly 40% of people diagnosed with type 2 diabetes stop taking their medication within the first year—a trend that puts their health at serious risk. In a new paper from UVA Health, diabetes experts ...

Tirzepatide is approved for 3 indications in the US: type 2 diabetes, chronic weight management, and obstructive sleep apnea.

Type 5 diabetes, a malnutrition-related condition, affects 20–25 million people globally—mainly in Asia and Africa—and is ...

Mass General Brigham researchers found that by December 2023, more than 1 in 3 of the medications being started for type 2 diabetes treatment were GLP-1RA-based medications, such as semaglutide or tir ...

A study led by two undergraduate students at the University of Galway found that GLP-1 receptor agonists, a type of diabetes ...

A research paper by scientists at The Second Affiliated Hospital of Zhejiang University School of Medicine presented the ...

In this parallel design, randomized trial, intensive treatment of systolic blood pressure (SBP) resulted in a lower incidence ...

Semaglutide is an injectable medication that treats type 2 diabetes and obesity by regulating blood sugar levels. A ...

The American Heart Association has released a statement detailing cardiometabolic considerations for survivors of childhood ...